Benefits

Future Genomics 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in multiomics, next-generation sequencing, and diagnostics for the advancement of global healthcare.

 

Benefits of attending include:

• Two days of in-depth presentations revealing the very latest market intelligence addressing the industry’s collective challenges by sharing results and experiences.
• Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
• Updates on regional projects and research led by leading genomics experts detailing their experiences, findings, and new proposals.
• Technical presentations from across the industry showcasing the latest results from recent tests and trials, technological developments, and new technical know-how.
• New case studies on specific examples from leading industry experts in multiomics and next-generation sequencing initiatives.
• Unique opportunity to integrate with a multitude of biotech, pharmaceutical, diagnostic companies, and to seek new opportunities in this evolving industry.

 

Attending this conference will enable you to:

• Understand the current market dynamics of genomics and the healthcare industry
• Learn how to develop strategies for the advancement of global healthcare using the latest technologies and techniques
• Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
• Discuss new innovations and technological developments in multiomics and next-generation sequencing
• Access different ideas and perspectives from a multitude of experts and allied industries combining regional experiences

 

Who should attend?

This event is aimed at leading biotech, pharmaceutical, and diagnostic companies, along with government and policy think tanks, seeking to learn more about the latest technologies and technical know-how in genomic sequencing for clinical diagnostics and to build alliances for developing a global genomic surveillance system. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:

 

Genomics Research	Next-Generation Sequencing	Business Development
Translational Research	Immuno-Oncology	Clinical Trials and Approvals
Multiomics Research	Biotechnology Research	Manufacturing Research & Innovation
Clinical Diagnostics	Pathology	Research and Development
Companion Diagnostics	Bio-Surveillance	Strategy, Projects, & Public Affairs
Clinical Trials	Spatial Biology	Sales and Marketing Initiatives
Epidemiology	System Biology and Research	Legal and Regulatory
Bioinformatics	Precision Medicine	Equipment Certification Services
Molecular Medicine	Laboratory Equipment	News Reporting and Journalism

 

From the following industries and companies:

Biotechnology Companies	Genomic and Pathology Laboratories	Associations and Alliances
Pharmaceutical Companies	Clinical Research Organizations	Universities and Academia
Biopharmaceutical Companies	Precision Medicine Researchers	Research and Development
Diagnostic Companies	NGS Equipment Manufacturers	Government Agencies
Global Healthcare Providers	Omics Research Companies	Consultants and Advisors
Next-Generation Sequencing Companies	Spatial Biology Companies	Public Consultation Groups
Cancer Research & Treatment	Molecular Medicine Companies	Legal and Compliance Services
Translational Research Companies	Non-Governmental Organisations	News Reporters and Journalists

 

Book now
To secure your place at Future Genomics 2023, or if you require more information, please contact delegates@iQ-Hub.com.